US$ 27.25
history of glp-1 drugs Reflections on the discovery as a satiety hormone: Implications for obesity therapy and future directions Timeline of GLP-1 discovery and
Description
Lancet 2002;359:824830 [DOI] [PubMed] [Google Scholar] 12.Gupta V

Effect of liraglutide therapy on liver fat content in patients with inadequately controlled type 2 diabetes: the Lira-NAFLD study

Some GLP-1 and related medications are approved for chronic weight management in eligible adults without diabetes

Preclinical studies have found that Ex-4 significantly upregulates Sirt3 expression in glioblastoma by activating the GLP-1R, which subsequently inhibits the growth, migration, invasion, and epithelial-mesenchymal transition of glioma cells [87]

[DOI] [PubMed] [Google Scholar] 104.Jastreboff A.M., Aronne L.J., Ahmad N.N., et al

Available from: Deanfield J, Verma S, Scirica BM, Kahn SE, Emerson SS, Ryan D et al (2024) Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial
